Inicio
pct-off 70-90
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

4.9 (735) · € 8.00 · En stock

IJMS, Free Full-Text

Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications

Frontiers The impact of microbiome dysbiosis on T cell function within the tumor microenvironment (TME)

Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target, Experimental Hematology & Oncology

CD19 CAR-T cell therapy for Relapsed or Refractory Diffuse Large B Cell Lymphoma; Why does it Fail? - ScienceDirect

Infections after chimeric antigen receptor (CAR)‐T‐cell therapy for hematologic malignancies - Kampouri - 2023 - Transplant Infectious Disease - Wiley Online Library

Frontiers Predictive short/long-term efficacy biomarkers and resistance mechanisms of CD19-directed CAR-T immunotherapy in relapsed/refractory B- cell lymphomas

The heightened importance of the microbiome in cancer immunotherapy: Trends in Immunology

IJMS, Free Full-Text

Potential links between the microbiota and T cell immunity determine the tumor cell fate

Infections after chimeric antigen receptor (CAR)‐T‐cell therapy for hematologic malignancies - Kampouri - 2023 - Transplant Infectious Disease - Wiley Online Library